Your browser doesn't support javascript.
loading
Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era.
Xue, Yu-Juan; Cheng, Yi-Fei; Lu, Ai-Dong; Wang, Yu; Zuo, Ying-Xi; Yan, Chen-Hua; Wu, Jun; Sun, Yu-Qian; Suo, Pan; Chen, Yu-Hong; Chen, Huan; Jia, Yue-Ping; Liu, Kai-Yan; Han, Wei; Xu, Lan-Ping; Zhang, Le-Ping; Huang, Xiao-Jun.
Afiliación
  • Xue YJ; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.
  • Cheng YF; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Lu AD; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.
  • Wang Y; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Zuo YX; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.
  • Yan CH; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Wu J; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.
  • Sun YQ; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Suo P; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Chen YH; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Chen H; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Jia YP; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China.
  • Liu KY; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Han W; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Xu LP; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China.
  • Zhang LP; Department of Pediatrics, Peking University People's Hospital, Peking University, Beijing, China. Electronic address: zhangleping@pkuph.edu.cn.
  • Huang XJ; Department of Hematology, Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Peking University, Beijing, China. Electronic address: xjhrm@medmail.com.cn.
Biol Blood Marrow Transplant ; 25(8): 1611-1620, 2019 08.
Article en En | MEDLINE | ID: mdl-30537550
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cromosoma Filadelfia / Trasplante de Células Madre Hematopoyéticas / Inhibidores de Proteínas Quinasas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Quimioterapia de Inducción / Mesilato de Imatinib Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cromosoma Filadelfia / Trasplante de Células Madre Hematopoyéticas / Inhibidores de Proteínas Quinasas / Leucemia-Linfoma Linfoblástico de Células Precursoras / Quimioterapia de Inducción / Mesilato de Imatinib Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos